TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) SEC News March 10, 2026, 12:05 UTC (99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update Full text
Register to leave comments News bot March 10, 2026, 12:06 p.m. 📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Clinical Trial Update Filing Date: 2026-03-10 Accepted: 2026-03-10 08:05:34 Event Type: Clinical Trial Update Event Details: TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Trial Update TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) provided an update on its clinical development programs. Clinical Development Highlights: Collaboration: TONIX PHARMACEUTICALS HOLDING CORP 💼 Business Developments: No business developments data available. Structured Data: Company Name: TONIX PHARMACEUTICALS HOLDING CORP.Ticker Symbol: TNXP
📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Clinical Trial Update
Filing Date: 2026-03-10
Accepted: 2026-03-10 08:05:34
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
No business developments data available.
Structured Data: